SCHEMBL27238541

SCHEMBL27238541

Cc1onc2c1COc1c(NC(=O)OC(C)(C)C)cccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 3/20 0.39
▸ BRD9 Q9H8M2 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.35
▸ METAP1 P53582 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ HSP90AB1 P08238 1/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ LMNA P02545 3/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ TSHR P16473 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29810725 0.81 BRD9 (0.36) TDP2BRD9RXFP1METAP1HSP90AA1
SCHEMBL29842864 0.77 BRD9 (0.39) TDP2BRD9RXFP1METAP1HSP90AA1
SCHEMBL25897313 0.77 BRD9 (0.39) TDP2BRD9RXFP1METAP1HSP90AA1
SCHEMBL25897321 0.72 MEN1 (0.39) BRD9RXFP1METAP1ALDH1A1HSP90AA1
SCHEMBL25897332 0.72 BRD9 (0.36) TDP2BRD9RXFP1METAP1HSP90AA1
SCHEMBL25574384 0.69 MAP3K5 (0.50) BRD9IDO1
SCHEMBL27238487 0.69 ADRA2A (0.35) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL27238486 0.69 HSD17B10 (0.34) ALDH1A1KMT2ALMNAMEN1TSHR
SCHEMBL16745998 0.69 TDP2 (0.42) TDP2BRD9ALDH1A1HSP90AA1HSP90AB1
SCHEMBL30317135 0.69 MRGPRX1 (0.46) BRD9RXFP1ALDH1A1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240189309-A1 TYK2 INHIBITORS AND USES THEREOF SUDO BIOSCIENCES LIMITED (GB) 2024-06-13 — — US disclosed
WO-2022175745-A1 TYK2 INHIBITORS AND USES THEREOF SUDO BIOSCIENCES LIMITED (GB) 2022-08-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240189309-A1 TYK2 INHIBITORS AND USES THEREOF TYK2, JAK2, JAK1 TDP2 173/4885BRD9 430/4885RXFP1 1816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback